• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咖啡剂量与非酒精性脂肪性肝病的系统评价和剂量-反应荟萃分析。

A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease.

机构信息

Department of Infectious Diseases, the First Affiliated Hospital of Wenzhou Medical University, Hepatology Institute of Wenzhou Medical University, Wenzhou Key Laboratory of Hepatology, Wenzhou, Zhejiang, China.

Department of Infectious Diseases, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.

出版信息

Clin Nutr. 2019 Dec;38(6):2552-2557. doi: 10.1016/j.clnu.2018.11.030. Epub 2018 Dec 4.

DOI:10.1016/j.clnu.2018.11.030
PMID:30573353
Abstract

OBJECTIVE

Nonalcoholic fatty liver disease (NAFLD) is the most predominant chronic liver disease worldwide. Effect of coffee on NAFLD risk and its potential dose-response patterns were explored in the study.

DESIGN

PubMed, Web of Science, MEDLINE, Cochrane and Embase were searched up to 10 April 2018. We performed pair-wise meta-analysis of <1 cup per day vs. 1-2 cups per days or >2 cups per day to pool the relative risks (RRs) and corresponding 95% confidence intervals (CIs). And dose-response analysis was used to estimate relationship of NAFLD occurrence with coffee intake.

RESULTS

Seven articles were included with 4825 cases and 49,616 non-cases. Compared with <1 cup, 1-2 cups or >2 cups of coffee consumption per day were not significantly associated with NAFLD occurrence, and RR were 0.97 (95% CI: 0.85-1.11) and 0.88 (95%CI: 0.72-1.06). However, the summary RR of the highest versus lowest coffee consumption was 0.94 (95% CI: 0.92-0.97). Dose-response meta-analysis presented a non-linearity curve relationship of coffee and NAFLD occurrence while coffee consumption >3 cups per day reduced NAFLD significantly.

CONCLUSION

Coffee intake level more than 3 cups was observed lower risk of NAFLD than <2 cups per day. Although the risk of NAFLD was inversely associated with coffee consumption, while relevance may not be very close and more observational studies would be needed to verify the relationship of coffee and NAFLD.

摘要

目的

非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病。本研究旨在探讨咖啡对 NAFLD 风险的影响及其潜在的剂量反应模式。

设计

检索了 PubMed、Web of Science、MEDLINE、Cochrane 和 Embase 数据库,截至 2018 年 4 月 10 日。我们对每天饮用<1 杯与 1-2 杯或>2 杯咖啡进行了两两荟萃分析,以汇总相对风险(RR)及其相应的 95%置信区间(CI)。并进行了剂量-反应分析,以评估咖啡摄入与 NAFLD 发生之间的关系。

结果

共纳入 7 项研究,包含 4825 例病例和 49616 例非病例。与每天饮用<1 杯相比,每天饮用 1-2 杯或>2 杯咖啡与 NAFLD 发生无显著相关性,RR 分别为 0.97(95%CI:0.85-1.11)和 0.88(95%CI:0.72-1.06)。然而,最高与最低咖啡摄入量的汇总 RR 为 0.94(95%CI:0.92-0.97)。剂量-反应荟萃分析显示咖啡与 NAFLD 发生之间呈非线性曲线关系,而每天饮用咖啡>3 杯可显著降低 NAFLD 的发生风险。

结论

与每天饮用<2 杯相比,每天饮用>3 杯咖啡可降低 NAFLD 的发病风险。尽管咖啡摄入量与 NAFLD 呈负相关,但相关性可能不太密切,需要更多的观察性研究来验证咖啡与 NAFLD 的关系。

相似文献

1
A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease.咖啡剂量与非酒精性脂肪性肝病的系统评价和剂量-反应荟萃分析。
Clin Nutr. 2019 Dec;38(6):2552-2557. doi: 10.1016/j.clnu.2018.11.030. Epub 2018 Dec 4.
2
Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.咖啡和茶的摄入量与非酒精性脂肪肝及代谢综合征的关系:观察性研究的系统评价和荟萃分析
Clin Nutr. 2016 Dec;35(6):1269-1281. doi: 10.1016/j.clnu.2016.03.012. Epub 2016 Mar 30.
3
Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.咖啡摄入对非酒精性脂肪性肝病发病率、患病率和显著肝纤维化风险的影响:观察性研究的系统评价和荟萃分析。
Nutrients. 2021 Aug 30;13(9):3042. doi: 10.3390/nu13093042.
4
Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.咖啡消费与非酒精性脂肪性肝病风险:一项系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2017 Feb;29(2):e8-e12. doi: 10.1097/MEG.0000000000000776.
5
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.咖啡摄入对非酒精性脂肪性肝病和肝纤维化的影响:11 项流行病学研究的荟萃分析。
Ann Hepatol. 2021 Jan-Feb;20:100254. doi: 10.1016/j.aohep.2020.08.071. Epub 2020 Sep 10.
6
Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis.加工和未加工的红肉摄入与非酒精性脂肪性肝病风险的关系:系统评价和剂量反应荟萃分析。
J Glob Health. 2024 Apr 26;14:04060. doi: 10.7189/jogh.14.04060.
7
Coffee intake and the incident risk of cognitive disorders: A dose-response meta-analysis of nine prospective cohort studies.咖啡摄入量与认知障碍事件风险:九项前瞻性队列研究的剂量-反应荟萃分析。
Clin Nutr. 2017 Jun;36(3):730-736. doi: 10.1016/j.clnu.2016.05.015. Epub 2016 May 30.
8
Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies.习惯性喝咖啡与高血压风险:前瞻性观察研究的系统评价和荟萃分析。
Am J Clin Nutr. 2011 Jun;93(6):1212-9. doi: 10.3945/ajcn.110.004044. Epub 2011 Mar 30.
9
Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.胰岛素抵抗较低的非酒精性脂肪性肝病患者饮用咖啡与严重肝纤维化风险较低相关。
Liver Int. 2014 Sep;34(8):1250-8. doi: 10.1111/liv.12379. Epub 2013 Nov 24.
10
The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population.韩国普通人群中咖啡消费与非酒精性脂肪性肝病之间的关联。
Mol Nutr Food Res. 2021 Sep;65(18):e2100356. doi: 10.1002/mnfr.202100356. Epub 2021 Aug 3.

引用本文的文献

1
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病的发病机制与临床管理
Int J Mol Sci. 2025 Jun 14;26(12):5717. doi: 10.3390/ijms26125717.
2
Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.代谢功能障碍相关脂肪性肝病(MASLD)的管理——来自印度糖尿病专家视角的专家共识声明
Diabetes Obes Metab. 2025 Jun;27 Suppl 4(Suppl 4):3-20. doi: 10.1111/dom.16496. Epub 2025 Jun 2.
3
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.
美国胃肠病学会临床指南:肝病中的营养不良与营养建议
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
4
Coffee as a Source of Antioxidants and an Elixir of Youth.咖啡——抗氧化剂的来源与青春之泉。
Antioxidants (Basel). 2025 Feb 27;14(3):285. doi: 10.3390/antiox14030285.
5
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD.非酒精性脂肪性肝病炎症管理的治疗靶点与方法
Biomedicines. 2025 Feb 6;13(2):393. doi: 10.3390/biomedicines13020393.
6
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.营养、饮食策略、运动、生活方式及环境对非酒精性脂肪性肝病的预防作用。
Ann Med. 2025 Dec;57(1):2464223. doi: 10.1080/07853890.2025.2464223. Epub 2025 Feb 12.
7
Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9.咖啡因通过挽救肝脏中的双特异性磷酸酶9来改善代谢相关脂肪性肝炎。
Redox Biol. 2025 Mar;80:103499. doi: 10.1016/j.redox.2025.103499. Epub 2025 Jan 22.
8
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management.对抗肥胖相关肝病的营养策略:医学营养治疗在代谢功能障碍相关脂肪性肝病(MASLD)管理中的作用
Curr Obes Rep. 2025 Jan 11;14(1):7. doi: 10.1007/s13679-024-00597-6.
9
Causal effect of waist-to-hip ratio on non-alcoholic fatty liver disease: a mendelian randomization study.腰臀比对非酒精性脂肪性肝病的因果效应:一项孟德尔随机化研究
Front Genet. 2024 Nov 19;15:1414835. doi: 10.3389/fgene.2024.1414835. eCollection 2024.
10
Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).探索代谢功能障碍相关脂肪性肝病(MASLD)的多种治疗策略。
Life (Basel). 2024 Jul 3;14(7):844. doi: 10.3390/life14070844.